Vivos Therapeutics, Inc. Share-based Payment Arrangement, Expense
Vivos Therapeutics, Inc. (VVOS) reported Share-based Payment Arrangement, Expense of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $100.00K, a 66.67% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $200.00K, a 33.33% decline year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $700.00K, a 12.50% decline from fiscal 2024.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $800.00K, a 27.27% decline from fiscal 2023.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $1.10M, a 57.14% increase from fiscal 2022.
- Vivos Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $700.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-14 | $200.00K 10-Q · filed 2026-08-14 | $400.00K derived: sum of 3 quarters · filed 2026-08-14 | $500.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-20 | $300.00K derived: sum of 2 quarters · filed 2026-05-20 | $400.00K derived: sum of 3 quarters · filed 2026-05-20 | $700.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $200.00K derived: sum of 2 quarters · filed 2026-04-15 | $500.00K derived: sum of 3 quarters · filed 2026-08-14 | $700.00K 10-K · filed 2026-04-15 | ||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-19 | $400.00K derived: sum of 2 quarters · filed 2026-08-14 | $600.00K 10-Q · filed 2025-11-19 | $800.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-14 | $600.00K 10-Q · filed 2026-08-14 | $300.00K 10-Q · filed 2025-08-19 | $700.00K derived: sum of 3 quarters · filed 2026-08-14 | $800.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $300.00K 10-Q · filed 2026-05-20 | $400.00K derived: sum of 2 quarters · filed 2026-05-20 | $500.00K derived: sum of 3 quarters · filed 2026-05-20 | $1.10M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $200.00K derived: sum of 2 quarters · filed 2026-04-15 | $800.00K derived: sum of 3 quarters · filed 2026-04-15 | $800.00K 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-19 | $700.00K derived: sum of 2 quarters · filed 2025-11-19 | $700.00K 10-Q · filed 2025-11-19 | $1.10M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $600.00K 10-Q · filed 2025-08-19 | $300.00K 10-Q · filed 2024-08-14 | $600.00K 10-Q · filed 2025-08-19 | $1.00M derived: sum of 3 quarters · filed 2025-08-19 | $1.20M derived: sum of 4 quarters · filed 2025-08-19 | |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-15 | $400.00K derived: sum of 2 quarters · filed 2025-05-15 | $600.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.00M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $300.00K derived: sum of 2 quarters · filed 2025-03-31 | $700.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.10M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-14 | $600.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.00M 10-Q · filed 2024-11-14 | $1.30M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-14 | $800.00K 10-Q · filed 2024-08-14 | $1.10M derived: sum of 3 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $500.00K 10-Q · filed 2023-06-08 | $700.00K derived: sum of 2 quarters · filed 2023-06-08 | ||||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $700.00K 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | $500.00K 10-Q · filed 2022-12-20 | |||||
| 2022-03-31 | $200.00K 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |